Do we really want to take it all the way Gassy ? Yes we get huge upside but for a small biotech ex Australia to make it all the way are few and far between - yes CSL of course but how many others have failed between where we are now and selling their product on the open market ?
Ideally we partner in some way early next year, this is when i see the re-rate happening. One thing is clear, our leverage in any future partnership has increased significantly with the cash in the bank
Do we really want to take it all the way Gassy ? Yes we get huge...
-
- There are more pages in this discussion • 228 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
